top of page

The Technology

QS® Microencapsulation’s can be applied to virtually anything Liquid, Lotion, Cream, Semi-Solid, or Dissolvable to create ingredients and products that are healthier to use, safer to handle, and more efficient.

 

Particle size, characteristics, and delivery method can be customized depending on the intended use and desired results. The focus of the team at CoLabs is to develop exceptionally safe drug and chemical products that provide maximum effectiveness at the targeted treatment sites while reducing the potential for unintended consequences.

QS-logo-grey.png

New Products in 2023

We plan to design multipurpose formulations and continue the testing process on this technology:

  • Naturally Absorbent Encapsulate

  • Medical Encapsulated Cross-Linked Mesh 

  • Agricultural and Veterinary Applications 

  • Bug Repellents

  • Pet Products

  • Sunscreens

  • Cosmetics

  • Topical Pharmaceuticals

colabs_png.png

29 Issued Patents

COLABS vision was established in 2008 after 6 patents were issued during 2006 – 2007 for the new QUANTASPHERE® technology.  Registered in the USA, Europe, Mexico, and Japan, the 29 issued patents contain:
Broad Claims, Multiple Encapsulates, Wide Applications and Ingredient Bases. 

​

There are 15 pending patents as of June 2023.

FDA-Logo.jpg

FDA Approved

QS® Formulations help provide targeted delivery of FDA regulated cosmetics and drugs. The potential threat to users of topical skin medications provides the key significance for our unique science for medicine and vast consumer products. Notably, the FDA is in the process of developing new testing protocols (MUsT) for topical OTC drugs to evaluate their effects on the body when absorbed.

Klenskin-png.png

KLĒNSKIN™ Sunscreen

Designed by a Board-Certified Dermatologist,  Laura Cohen, KLĒNSKIN SUNSCREENS are on the market now. Increased SPF with lower actives concentrations, greater photostability, decreased skin penetration, and non-oily feel highlight some of the benefits of the KLENSKIN Sunscreen Brand.

Colabs_qti.png

Manufacturing Process

The first step in the process is to encapsulate the ingredients. This is the most critical step from a product efficacy perspective and is conducted independent of the large-scale manufacturing process. Once encapsulated the production run commences to create bulk formulations which are then bottled, labeled, and packaged. Throughout the process, CoLabs conducts testing to ensure specification standards are met and, if an OTC, testing is completed for microbes and actives.

qs_qti.png

Family of IP

QUANTASPHERE® Technology is currently being evaluated for an encapsulated version of a transdermal patch without the need for a reservoir. Management plans to develop, test, and expand this advanced transdermal delivery technology for multiple potential applications. CoLabs IP provides a novel enhanced delivery system for the skin and is applicable for FDA approved, advanced pharmaceutical drugs and use with EPA pest repellents, pesticides, and herbicides. 

bottom of page